Research programme: dual prostaglandin E2/prostaglandin E4 receptor agonists - Serono

Drug Profile

Research programme: dual prostaglandin E2/prostaglandin E4 receptor agonists - Serono

Alternative Names: AS 01; AS 02; Research programme: dual EP2/EP4 receptor agonists - Serono

Latest Information Update: 12 Mar 2008

Price : $50

At a glance

  • Originator Merck Serono
  • Class Small molecules
  • Mechanism of Action Dinoprostone agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 14 Sep 2005 Suspended - Preclinical for Asthma in USA (unspecified route)
  • 13 Sep 2004 Preclinical trials in Asthma in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top